Reuters: Regulatory News: UPDATE 1-CVS still sees rivals' resolved spat boosting profit

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-CVS still sees rivals' resolved spat boosting profit Jul 19th 2012, 14:51 July 19 | Thu Jul 19, 2012 10:51am EDT July 19 (Reuters) - CVS Caremark Corp said business it had gained from the impasse between rivals Walgreen Co and Express Scripts Holding Co, which was resolved on Thursday, should add about 5 cents per share to its profit in the second half of the year. Walgreen, the largest U.S. drugstore chain, stopped filling prescriptions for Express Scripts patients at the end of 2011 after the companies were unable to agree on contract terms. Sales at CVS, the No. 2 chain, rose as a result. On Thursday, Walgreen and Express Scripts said Walgreen would be part of Express Scripts' broad retail network starting on Sept. 15. Now that its rivals reached a resolution, CVS said it expected to retain at least 50 percent of the business it gained. Previously, CVS only included the benefit it anticipated from the spat through the end of the second quarter. In May, it forecast a full-year profit of $3.23 to $3.33 per share.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions